Eli Lilly

IRS: 350470950
LLY
Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Founded
1901 (121 years)
Investor RelationsSEC
Revenue
27 billion (2021)

Want to see more? Sign up!